Document is current

Any future updates will be listed below

Is regorafenib providing clinically meaningful benefits to pretreated patients with metastatic colorectal cancer?

Crossref DOI link: https://doi.org/10.1007/s12094-016-1499-8

Published Online: 2016-04-01

Published Print: 2016-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark